CTIS: a milestone in European clinical research

by Sermes CRO

The implementation of CTIS is a crucial step towards a more efficient and competitive clinical research ecosystem in Europe, benefiting both researchers and patients

Read more

Ensayo pionero para tratar con un nuevo CAR-T académico a pacientes con mieloma múltiple en recaída

by Instituto de Investigación Biomédica de Salamanca - IBSAL

La colaboración del Complejo Asistencial Universitario de Salamanca a través del IBSAL y del Hospital Virgen de Rocío, mediante el Instituto de Biomedicina de Sevilla, ha logrado la financiación d...

Read more

Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated

by Fundació Clínic per a la Recerca Biomèdica

Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulatory authority (AEMPS).

Read more

Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline

by Ysios Capital

The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial

Read more

Anaconda Biomed Enrolls First U.S. Patient in the ATHENA Clinical Trial Evaluating ANA Funnel Catheter for Ischemic Stroke Treatment

by Ysios Capital

Anaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, today announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical ...

Read more

La Arrixaca se embarca, a través del IMIB, en el primer ensayo clínico de España para tratar heridas con sustitutos de piel del propio paciente

by Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca

El fin último es poder tratar con esa piel bioimpresa a pacientes infantiles con grandes quemaduras, ya que con el uso de piel autóloga (del propio paciente) se evita el rechazo que se produce cuand...

Read more

Accure Therapeutics Obtains €1.5 Million in Grants to Accelerate Development of Its Parkinson’s Drug ACT-02

by Parc Científic de Barcelona

The funding will drive two preclinical development programs for its groundbreaking drug, ACT-02—an innovative compound with potential disease-modifying properties. ACT-02 functions as an inhibitor o...

Read more

Andalucía ofrece a los pacientes con párkinson las terapias más avanzadas para su tratamiento

by Professional Newco

Más de 500 pacientes ya se han beneficiado de la estimulación cerebral profunda que, junto al HIFU y la radiación Gammaknife, constituyen las técnicas más innovadoras en los casos más complejos ...

Read more

Technology to enhance patient recruitment for clinical trials

by Sermes CRO

Nowadays, technology provides us with excellent tools to optimize the patient recruitment process for clinical trials, improving efficiency and expanding the reach of information among suitable partic...

Read more

ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer

by Oryzon Genomics

Oryzon Genomics announced today that the first patient has been dosed in a Phase I/II trial of iadademstat, Oryzon’s potent and selective LSD1 inhibitor, in combination with immune checkpoint inhibi...

Read more

Qué hacer si no completaste la transición de tu ensayo clínico al CTIS

by Sermes CRO

¿Qué pasa si no se ha completado la transición de tu ensayo clínico al Reglamento (UE) 536/2014 y, por tanto, al CTIS? El reglamento contempla una serie de acciones y medidas correctivas para esto...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream